Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin.
10.4046/trd.2005.59.5.536
- Author:
Jin Yong JUNG
1
;
Gyu Young HUR
;
Ki Hwan JUNG
;
Hae Chul JUNG
;
Sung Yong LEE
;
In Keun CHOI
;
Sang Yeub LEE
;
Je Hyeong KIM
;
Jae Hong SEO
;
Chol SHIN
;
Jae Jeong SHIM
;
Kwang Ho IN
;
Kyung Ho KANG
;
Se Hwa YOO
Author Information
1. Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea. chepraxis@korea.com
- Publication Type:Case Report
- Keywords:
Oxaliplatin;
Fluorouracil;
Leucovorin;
Chemotherapy;
Pulmonary fibrosis
- MeSH:
Diarrhea;
Drug Therapy*;
Drug Therapy, Combination;
Fluorouracil*;
Humans;
Leucovorin*;
Neutropenia;
Pulmonary Fibrosis*;
Stomach Neoplasms
- From:Tuberculosis and Respiratory Diseases
2005;59(5):536-540
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The combination of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) has recently been shown to be beneficial in advanced colorectal and gastric cancers. The side effects of this regimen include neutropenia, diarrhea and neurosensory toxicity. However, case reports on the pulmonary toxicities of this regimen are very limited. Especially, the development of pulmonary fibrosis has never been cited in the literature. Herein is reported the case of a patient treated with oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in whom pulmonary fibrosis developed, but which improved after steroid pulse therapy.
